Use of NICE-appraised medicines in the NHS in England

Name: Use of NICE-appraised medicines in the NHS in England
Creator: NHS Digital
License: https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/

data.gov.uk (National Data Library) OGL-UK-3.0 ↪ webpage — more clicking needed NHS Digital · updated 2015-04-21

Open at publisher ↗

The National Institute for Health and Care Excellence (NICE) technology appraisal process assesses the clinical and cost effectiveness of new and existing drugs and treatments, and provides guidance on their use by the NHS. As part of the Pharmaceutical Price Regulation Scheme (PPRS) agreement which came into operation on 1 January 2009, the Department of Health (DH) and the Association of the British Pharmaceutical Industry agreed that the DH would review the variation in uptake of selected medicines in the NHS in England.

Files & links (2)

Resource	Format	Verified	Size
PUB13413	HTML	↪ webpage — more clicking needed
use-nice-app-med-nhs-exp-stat-eng-12-tab.xlsx	XLS	unchecked

More from NHS Digital

Contains public sector information licensed under the Open Government Licence v3.0 and other licences as stated per dataset. Metadata collated by the UK Open Data Index.